#1 Clinical Trials Search in Europe

Duloxetine

Duloxetine, also known by the brand name Cymbalta, is a medication that has been studied in various clinical trials for its potential benefits in treating different conditions. These trials have explored its use in managing pain, depression, stress urinary incontinence, and other health issues. The research aims to evaluate duloxetine’s effectiveness, safety profile, and optimal dosing across diverse patient populations.

Table of Contents

What is Duloxetine?

Duloxetine, also known by its brand name Cymbalta, is a medication used to treat various conditions. It belongs to a class of drugs called serotonin and norepinephrine reuptake inhibitors (SNRIs)[1]. Duloxetine works by increasing the levels of two important chemicals in the brain: serotonin and norepinephrine. These chemicals play a crucial role in mood regulation and pain perception[2].

Medical Conditions Treated

Duloxetine is used to treat several medical conditions, including:

  • Diabetic Peripheral Neuropathic Pain (DPNP): This is a type of nerve pain caused by diabetes. Duloxetine has been shown to be effective in reducing this pain[3].
  • Fibromyalgia: A condition characterized by widespread muscle pain and tenderness[4].
  • Chronic Pain: Including pain associated with osteoarthritis and lower back pain[5].
  • Depression: Duloxetine is used to treat major depressive disorder[4].
  • Anxiety: It can help manage generalized anxiety disorder[4].
  • Stress Urinary Incontinence: In some countries, duloxetine is used to treat stress urinary incontinence in women[6].

How Duloxetine Works

Duloxetine works by increasing the levels of serotonin and norepinephrine in the brain. These chemicals are neurotransmitters, which means they help transmit signals between nerve cells. By increasing their levels, duloxetine can help improve mood, reduce anxiety, and decrease pain perception[2].

In the case of pain conditions like diabetic neuropathy, duloxetine is believed to strengthen the body’s natural pain-suppressing mechanisms. It does this by enhancing the function of the descending inhibitory pain pathways, which are responsible for reducing the perception of pain[4].

Dosage and Administration

Duloxetine is typically taken orally in the form of a hard gelatinous capsule. The dosage can vary depending on the condition being treated and the individual patient’s needs. Some common dosages include:

  • 30 mg once daily
  • 60 mg once daily
  • 60 mg twice daily (in some cases)

It’s important to note that your doctor will determine the right dosage for you based on your specific condition and how you respond to the medication[1][2].

Effectiveness

Several studies have shown duloxetine to be effective in treating various conditions:

  • Diabetic Peripheral Neuropathic Pain: Clinical trials have demonstrated that duloxetine can significantly reduce pain in patients with this condition[3].
  • Fibromyalgia: Duloxetine has been shown to reduce pain and improve functioning in patients with fibromyalgia[4].
  • Depression and Anxiety: Studies have found duloxetine to be effective in treating major depressive disorder and generalized anxiety disorder[4].
  • Stress Urinary Incontinence: Some studies have shown that duloxetine can help reduce the frequency of incontinence episodes in women with this condition[6].

Side Effects and Safety

Like all medications, duloxetine can cause side effects. Common side effects may include:

  • Nausea
  • Dry mouth
  • Constipation
  • Fatigue
  • Decreased appetite
  • Increased sweating

More serious side effects, although rare, can occur. These may include changes in blood pressure, liver problems, or allergic reactions. It’s important to report any unusual symptoms to your doctor immediately[5].

Special Populations

Duloxetine has been studied in various populations:

  • Elderly Patients: Duloxetine can be used in older adults, but dosage adjustments may be necessary[1].
  • Different Ethnic Groups: Studies have been conducted to evaluate the effectiveness of duloxetine in different ethnic populations, including Hispanic and African American women for stress urinary incontinence[6].
  • Chinese Population: A study was conducted to evaluate the pharmacokinetics (how the body processes the drug) of duloxetine in Chinese Han healthy subjects[7].

It’s important to note that while duloxetine can be an effective treatment for various conditions, it should only be taken under the guidance of a healthcare professional. Your doctor will consider your specific situation, including any other medications you’re taking or health conditions you have, before prescribing duloxetine.

Aspect Details
Primary Conditions Studied Chronic pain, Depression, Stress urinary incontinence, Fibromyalgia, Neuropathic pain
Dosage Range 30mg to 120mg daily, often with gradual increase
Administration Method Oral capsules
Common Outcome Measures Pain scales, Quality of life assessments, Depression rating scales, Condition-specific questionnaires
Trial Durations Ranging from a few weeks to over a year
Safety Monitoring Adverse event tracking, Physical examinations, Laboratory tests
Patient Populations Varied, including specific ethnic groups and patients with comorbidities
Study Designs Double-blind placebo-controlled, Open-label, Crossover studies

FAQ

  • What conditions is duloxetine being studied for in clinical trials? Clinical trials are investigating duloxetine for various conditions, including chronic pain after knee surgery, systemic lupus erythematosus pain, diabetic peripheral neuropathic pain, stress urinary incontinence, chronic depression, fibromyalgia, and chemotherapy-induced neurotoxicity.
  • How is duloxetine administered in these trials? Duloxetine is typically administered orally in capsule form. Dosages vary depending on the study, ranging from 30mg to 120mg per day. Some trials start with a lower dose and gradually increase it over time.
  • What are some common outcome measures used in duloxetine trials? Common outcome measures include pain scales (like the Brief Pain Inventory), quality of life assessments (such as the SF-36 Health Survey), depression rating scales (like the Hamilton Depression Rating Scale), and specific symptom questionnaires related to the condition being studied.
  • Are there any notable side effects of duloxetine observed in these trials? While specific side effects vary between studies, researchers closely monitor for adverse events. Common side effects of duloxetine can include nausea, dry mouth, constipation, fatigue, and dizziness. The trials assess both the frequency and severity of any side effects.
  • How long do duloxetine clinical trials typically last? The duration of duloxetine trials varies widely depending on the study objectives. Some trials last just a few weeks, while others extend for several months or even up to a year to assess long-term safety and efficacy.

Ongoing Clinical Trials on Duloxetine

  • Study on Duloxetine and Benztropine Mesylate for Patients with Severe Functional Somatic Disorder

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Duloxetine for Reducing Chronic Pain After Inguinal Hernia Surgery in High-Risk Patients

    Recruiting

    3 1 1
    Investigated drugs:
    Spain

  • Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Germany Greece Italy Spain

  • Study Comparing Capsaicin Patch and Duloxetine for Patients with Chemotherapy-Induced Peripheral Neuropathy

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Spain

  • Study on Improving Quality of Life for Early Breast Cancer Patients Using Duloxetine and Furosemide to Manage Endocrine Therapy-Related Pain

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Cyprus France Poland Slovenia Spain

  • Study on Temporarily Stopping Duloxetine, Sertraline, and Paroxetine in Patients with Hip or Knee Osteoarthritis Undergoing Surgery

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany Italy Spain

  • Testing Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Germany Hungary Poland Spain

  • Study on Lacosamide and Duloxetine for Patients with Chemotherapy-Induced Neuropathic Pain

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Duloxetine: A medication that acts as a serotonin-norepinephrine reuptake inhibitor (SNRI), used to treat depression, anxiety, and various types of chronic pain.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the active drug being studied.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body over time.
  • Brief Pain Inventory (BPI): A widely used questionnaire that helps patients rate the severity of their pain and the impact of pain on daily functions.
  • Quality of Life (QoL): A measure of an individual's overall well-being, including physical, mental, and social aspects of their life.
  • Adverse Event: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.
  • Efficacy: The ability of a drug or treatment to produce the desired beneficial effect under ideal circumstances.
  • Double-blind Study: A type of clinical trial where neither the participants nor the researchers know who is receiving the active treatment and who is receiving the placebo.
  • Neuropathic Pain: Pain caused by damage or disease affecting the nervous system.
  • Fibromyalgia: A condition characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues.

References

  1. https://clinicaltrials.gov/study/NCT03729284
  2. https://clinicaltrials.gov/study/NCT03794154
  3. https://clinicaltrials.gov/study/NCT02215798
  4. https://clinicaltrials.gov/study/NCT01269866
  5. https://clinicaltrials.gov/study/NCT03792828
  6. https://clinicaltrials.gov/study/NCT00190905
  7. https://clinicaltrials.gov/study/NCT00933452